Nexa offers compounded GLP-1 (Semaglutide) prepared by licensed pharmacies for patients who qualify
Blurry or fluctuating vision Eye pain These are not just uncomfortable, temporary side effects
Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation
Even among those that don't report significant clinical side effects, the financial burden of these drugs, as well as the injectable nature of the most popular versions (which much be administered via subcutaneous injection), are major deterrents for many patients
:max_bytes(150000):strip_icc()/VWH-AmeliaManley-OzempicvsWegovyvsMounjaro-dc80b8c8de6243ec9b984cd4b5db5db4.jpg)
KEY TAKEAWAYS: Rising global burden of obesity, diabetes, hypertension, and cardiovascular diseases is accelerating demand for advanced cardiometabolic therapies Growing adoption of GLP-1 receptor agonists and SGLT2 inhibitors is transforming chronic disease management Increasing focus on integrated cardio-renal-metabolic care is improving patient outcomes and expanding therapeutic applications Advances in RNA-based therapeutics, gene-editing technologies, and precision medicine are creating new treatment opportunities Strong clinical pipelines targeting obesity, metabolic liver disease (MASH), lipid disorders, and heart failure are driving market expansion Strategic partnerships between pharmaceutical and biotechnology companies are accelerating drug development and commercialization North America leads the market due to advanced healthcare infrastructure, favorable reimbursement systems, and early adoption of innovative therapies, while Asia-Pacific is emerging as a high-growth region

Side effects usually involve gastrointestinal (GI) tract or digestive symptoms